Platelet-activating factor contributes to postischemic vasospasm

Journal of Surgical Research

Volumn 89, Issue 2, 2000, Pages 139-146

  Wang, Wei Z ^a   Guo, Shang Z ^a   Tsai, Tsu Min ^b   Anderson, Gary L ^b   Miller, Frederick N ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Ischemia reperfusion injury; Microcirculation; Platelet activating factor; Skeletal muscle; Vasospasm

Indexed keywords

IMIDAZOLE DERIVATIVE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOXANE A2; THROMBOXANE SYNTHASE INHIBITOR; [2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIUM LESION; LIMB SALVAGE; MALE; MICROCIRCULATION; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; THROMBOCYTE ACTIVATION; VASOSPASM;

EID: 0034030683     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5815     Document Type: Article

References (40)

1. Kerrigan C. L., Storland M. A. Ischemia reperfusion injury: A review. Microsurgery. 14:1993;165.
2. Menger M. D., Rucker M., Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: On the mechanisms of capillary "no-reflow" Shock. 8:1997;2.
3. Wang W. Z., Anderson G. L., Firrell J. C. Arteriole constriction following ischemia in denervated skeletal muscle. J. Reconstr. Microsurg. 11:1995;99.
4. Siemionow M., Wang W. Z., Anderson G. L., Firrell J. C. Leukocyte-endothelial interaction and capillary perfusion in ischemia/reperfusion of the rat cremaster muscle. Microcirc. Endothelium Lymphatics. 7:1991;183.
5. Quinones-Baldrich W. J., Chervu A., Hernander J. J., Colburn M., Moor W. S. Skeletal muscle function after ischemia: "no reflow" versus reperfusion injury. J. Surg. Res. 51:1991;5.
6. Feng L. J., Berger B. E., Lysz T. W., Shaw W. W. Vasoactive prostaglandins in the impending no reflow state: Evidence for a primary disturbance of microvascular tone. Plast. Reconstr. Surg. 81:1988;755.
7. Korthuis R. J., Granger D. N., Townsley M. I., Taylo A. E. The role of oxygen-derived free radicals in ischemia-induced increase in canine skeletal muscle vascular permeabililty. Circ. Res. 57:1988;599.
8. Ames A. III, Wright R. L., Kowada M., Thurston J. M., Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am. J. Pathol. 52:1968;437.
9. Hardy S. C., Homer-Vanniasinkam S., Gough M. J. The triphasic pattern of skeletal muscle blood flow in reperfusion injury: An experimental model with implications for surgery on the acutely ischemic lower limb. Eur. J. Vasc. Surg. 4:1990;587.
10. Kawata H., Aoki M., Mater I. E. Nitroglycerin improves functional recovery of neonatal lamb hearts after 2 hours of cold ischemia. Circulation. 88:1993;366.
11. Sternbergh W. C., Makhoul R. G., Adelman B. Nitric oxide-mediated, endothelium-dependent vasodilation is selectively attenuated in the postischemic extremity. Surgery. 114:1993;960.
12. Tsuji S., Sawamura A., Watanabe H., Takihara K., Park S. E., Azuma J. Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci. 48:1991;1745.
13. Maulik N., Liu X., Subramanian R., Das D. K. Release of endothelin during reperfusion of ischemic myocardium: ET-1 release from reperfused heart. Am. J. Cardiovasc. Pathol. 4:1992;133.
14. Nelson C. W., Wei E. P., Povlishock J. T., Kontos H. A., Moskowitz M. A. Oxygen radicals in cerebral ischemia. Am. J. Physiol. 263:1992;H1356.
15. Seccombe J. F., Pearson P. J., Schaff H. V. Oxygen radical-mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. J. Thorac. Cardiovasc. Surg. 107:1994;505.
16. Shepherd J. T., Katusic Z. S., Vedernikovy, Vanhoutte P. M. Mechanisms of coronary vasospasm: Role of endothelium. J. Mol. Cell Cardiol. 23:1991;125.
17. Pearson P. J., Lin P. J., Schaff H. V. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxation to aggregating platelet in the canine coronary artery: A possible cause of vasospasm after cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 103:1992;1147.
18. Wang W. Z., Anderson G. L., Acland R. D., Barker J. Endothelin-1 does not contribute to ischemia/reperfusion-induced vasoconstriction in skeletal muscle. J. Reconstr. Microsurg. 13:1997;439.
19. Wang W. Z., Anderson G. L., Fleming J. T., Peter F. W., Franken R. J. P. M., Acland R. D., Barker J. Lack of nitric oxide contributes to vasospasm during ischemia/reperfusion injury. Plast. Reconstr. Surg. 99:1997;1099.
20. McMurtry I. F., Morris K. G. Platelet-activating factors in pulmonary vasodilation in the rat. Am. Rev. Respir. Dis. 134:1986;757.
21. Chiba Y., Mikoda N., Kawasaki H., Ito K. Endothelium-dependent relaxant action of platelet-activating factor in the rat mesenteric artery. Naunn Schmiedeberg's Arch. Pharmacol. 241:1990;68.
22. Dillon P. K., Ritter A. B., Duran W. N. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: Dose-related relations and pathways of action. Circ. Res. 62:1988;722.
23. Meiniger G. A. Responses of sequentially branching macro- and microvessels during reactive hyperemia in skeletal muscle. Microvasc. Res. 34:1987;29.
24. O'Flaherty J. T., Wykle R. L. Biology and biochemisty of platelet-activating factor. Clin. Rev. Allergy. 1:1983;353.
25. Clark P. O., Hanahan D. J., Pinckard R. N. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim. Biophys. Acta. 628:1980;69.
26. Camussi G., Aglietta M., Malabasi F., Tetta A., Piacibello W., Sanavio F., Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J. Immunol. 131:1983;2397.
27. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol. Rev. 39:1987;97.
28. Montrucchio G., Alloatti G., Tetta C., De Luca R. Release of platelet-activating factor from ischemic-reperfusion rabbit heart. Am. J. Physiol. 256:1989;H1236.
29. Yin M., Kurvers H. A. J. M., Buurman W. A., Tangelder G. J., Booster M. H., Daremen J. H. C., Kondracki D. S., Kotstra G. Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. Transplant Proc. 27:1995;774.
30. Minor T., Isselhard W., Yamaguchi T. Involvement of platelet-activating factor in microcirculatory disturbances after global hepatic ischemia. J. Surg. Res. 58:1995;536.
31. Braquet P., Paubert-Braquet M., Koltai M., Bourgain R., Bussolono F., Hosford D. Is there a case for PAF antagonists in the treatment of ischemic states. Trends Pharmacol. Sci. 10:1989;23.
32. Adams J. G., Dhar A., Kikta M., Shukla S., Silver D. Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury. Surg. Forum. 45:1994;395.
33. Filep J., Herman F., Braquet P., Mozws T. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. Biochem. Biophys. Res. Commun. 158:1989;353.
34. Zhou W., McCollum M. O., Levine B. A., Olson M. S. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology. 16:1992;1236.
35. Felix S. B., Baumann G., Taschke P., Maus C., Berdel W. E. Cardiovascular reactions and respiratory events during platelet-activating factor-induced shock. Basic Res. Cardiol. 85:1990;217.
36. Maruyama M., Farber N. E., Vercellotti G. M., Jacob H. S., Gross G. J. Evidence for a role of platelet activating factor in the pathogenesis of irreversible but not reversible myocardial injury after reperfusion in dogs. Am. Heart J. 120:1990;510.
37. Turnage R. H., Kadesky K. M., Bartula L., Myers S. I. Pulmonary thromboxane release following intestinal reperfusion. J. Surg. Res. 58:1995;552.
38. 2 analogue, on reperfusion injury to rabbit lungs. Am. J. Respir. Crit. Care Med. 158:1998;1669.
39. Ikeda K., Nagashima T., Wu S., Yamaguchi M., Tamaki N. The role of calcium ion in anoxia/reoxygenation damage of cultured brain capillary endothelial cells. Acta Neurochir. Suppl. 70:1997.
40. Beasley T. C., Bari F., Thore C., Thrikawala N., Louis T., Busija D. Indomethacin attenuates early increases in inducible heat shock protein 70 after cerebral ischemia/reperfusion in piglets. Brain Res. Dev. Brain Res. 105:1998;125.